Hangzhou LifeReal Biotechnology
PrivateLast Round
Series B
May 1, 2022
Company Overview
Hangzhou LifeReal Biotechnology operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series B round in May 2022.
Hangzhou LifeReal Biotechnology is a medical supplies company that develops and produces life science and clinical diagnostic products.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou LifeReal Biotechnology Comparables
Compare Hangzhou LifeReal Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jiangsu Mole Bioscience Co., Ltd. | 86% | |
| Hangzhou Bigfish Bio-tech Co., Ltd. | 86% | |
| Coyote Bioscience Co., Ltd. | 83% |
For institutional investors. Book with your work email.
Hangzhou LifeReal Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2022 | ||||
| Series A Extension | Jul 16, 2020 | ||||
| Series A | May 31, 2019 | ||||
| Angel | Apr 1, 2017 |
For institutional investors. Book with your work email.
Hangzhou LifeReal Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zheshang Venture Capital | Series B, Series A Extension |
| YuanBio Venture Capital | Series B, Angel |
| GF Venture Capital | Series B |
| Huagai Capital | Series B, Series A |
| China Growth Capital | Series B, Series A Extension |
| Ennovation Ventures | Series B, Angel |
| 广发乾和投资有限公司 | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 95% MoM.
- May 15, 2026
Monthly visitors grew 191% MoM, reaching 704.
For institutional investors. Book with your work email.
Hangzhou LifeReal Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou LifeReal Biotechnology's valuation, stock price, and market status.
Is Hangzhou LifeReal Biotechnology a public or private company?
Hangzhou LifeReal Biotechnology is a private company.
What is the current stock price of Hangzhou LifeReal Biotechnology?
Hangzhou LifeReal Biotechnology is a private company, so its shares have no public market price. Caplight tracks Hangzhou LifeReal Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou LifeReal Biotechnology worth (valuation)?
Valuation information for Hangzhou LifeReal Biotechnology is not publicly available.
Can I buy Hangzhou LifeReal Biotechnology stock?
Hangzhou LifeReal Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou LifeReal Biotechnology's last funding round?
Hangzhou LifeReal Biotechnology's most recent funding round was Series B on May 1, 2022.
Who are the main investors in Hangzhou LifeReal Biotechnology?
Key investors in Hangzhou LifeReal Biotechnology include Zheshang Venture Capital, YuanBio Venture Capital, GF Venture Capital, Huagai Capital, China Growth Capital.
Will Hangzhou LifeReal Biotechnology IPO soon?
No public IPO plans have been announced for Hangzhou LifeReal Biotechnology.
How can I track Hangzhou LifeReal Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou LifeReal Biotechnology's shares on secondary markets.